Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S. N. Balaji"'
Autor:
Sayan Roy Chowdhury, Subrata Mondal, Balakrishnan Muthuraj, S. N. Balaji, Vishal Trivedi, Parameswar Krishnan Iyer
Publikováno v:
ACS Omega, Vol 3, Iss 7, Pp 8059-8066 (2018)
Externí odkaz:
https://doaj.org/article/aef2096d6231413e8e8af617464d15ef
Publikováno v:
Journal of Vector Borne Diseases, Vol 57, Iss 1, Pp 1-13 (2020)
Every year, millions of people are infected with malaria, resulting in significant economic losses to the developing and developed nations. The malaria parasite pursues a complicated life cycle in an invertebrate, mosquito and vertebrate host with se
Externí odkaz:
https://doaj.org/article/1093440cc9164394a4b3e05fc52f79b5
An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasite
Publikováno v:
Parasitology Research. 119:2025-2037
Leishmaniasis is a neglected tropical disease with no effective vaccines to date. Globally, it affects around 14 million people living in undeveloped and developing countries. Leishmania, which is the causative eukaryotic organism, possesses unique e
Publikováno v:
Journal of Proteins and Proteomics. 11:135-158
Leishmaniasis is a vector-borne protozoan disease caused by an intracellular parasite which globally affects 350 million people. This infectious disease mainly affects undeveloped and developing countries across the world. Chemotherapeutic therapies
Publikováno v:
Molecular Simulation. 46:419-428
Current vaccines used for polio are live attenuated oral polio vaccine and inactivated polio vaccine. Recently, in India, the relapse of virulence was observed in attenuated viruses resulting in ca...
Publikováno v:
International Journal of Peptide Research and Therapeutics. 26:2231-2240
Zika is one of the most dreaded viruses which has left mankind crippled for over years. Current no vaccines for Zika are available in the market and only a few are in the clinical trials. The conventional vaccine approach uses live-attenuated or inac